Childress Capital Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01M | Sell |
5,621
-50
| -0.9% | -$26.8K | 0.76% | 30 |
|
|
2025
Q1 | $2.38M | Buy |
5,671
+17
| +0.3% | +$7.14K | 0.69% | 28 |
|
|
2024
Q4 | $2.34M | Sell |
5,654
-126
| -2% | -$52.1K | 0.65% | 30 |
|
|
2024
Q3 | $2.92M | Buy |
5,780
+3
| +0.1% | +$1.52K | 0.79% | 26 |
|
|
2024
Q2 | $2.81M | Buy |
5,777
+12
| +0.2% | +$5.85K | 0.79% | 25 |
|
|
2024
Q1 | $3.11M | Sell |
5,765
-52
| -0.9% | -$28.1K | 0.9% | 26 |
|
|
2023
Q4 | $3.23M | Buy |
5,817
+15
| +0.3% | +$8.33K | 0.96% | 23 |
|
|
2023
Q3 | $2.53M | Buy |
5,802
+602
| +12% | +$263K | 0.83% | 26 |
|
|
2023
Q2 | $2.61M | Hold |
5,200
| – | – | 1.11% | 17 |
|
|
2023
Q1 | $2.6M | Sell |
5,200
-549
| -10% | -$275K | 1.14% | 16 |
|
|
2022
Q4 | $2.35M | Buy |
5,749
+124
| +2% | +$50.6K | 0.78% | 20 |
|
|
2022
Q3 | $1.83M | Buy |
5,625
+85
| +2% | +$27.7K | 0.71% | 28 |
|
|
2022
Q2 | $1.94M | Buy |
5,540
+57
| +1% | +$20K | 0.77% | 23 |
|
|
2022
Q1 | $3M | Buy |
5,483
+32
| +0.6% | +$17.5K | 1.05% | 15 |
|
|
2021
Q4 | $3.59M | Sell |
5,451
-50
| -0.9% | -$32.9K | 1.48% | 14 |
|
|
2021
Q3 | $3.42M | Buy |
5,501
+7
| +0.1% | +$4.35K | 1.39% | 15 |
|
|
2021
Q2 | $3.47M | Sell |
5,494
-1
| -0% | -$631 | 1.58% | 13 |
|
|
2021
Q1 | $2.69M | Buy |
5,495
+97
| +2% | +$47.5K | 1.23% | 18 |
|
|
2020
Q4 | $2.7M | Buy |
+5,398
| New | +$2.7M | 1.58% | 11 |
|